Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.

@article{Camisasca1994ParenteralCF,
  title={Parenteral calcitonin for metabolic bone disease associated with primary biliary cirrhosis.},
  author={M Camisasca and Andrea Crosignani and Pier Maria Battezzati and Walter Albisetti and Giuseppe Grandinetti and Luca Pietrogrande and Arianna Biffi and Massimo Zuin and Mauro Podda},
  journal={Hepatology},
  year={1994},
  volume={20 3},
  pages={633-7}
}
No satisfactory treatment is available for metabolic bone disease associated with primary biliary cirrhosis. On the basis of the similarities to postmenopausal osteoporosis, the rationale exists for calcitonin to be tested in clinical studies in patients with primary biliary cirrhosis-associated osteoporosis. We evaluated the effect of calcitonin on bone metabolism and mineral density in 25 women with primary biliary cirrhosis and severe osteopenia. After 6 mo of observation, patients received… CONTINUE READING
21 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Similar Papers

Loading similar papers…